Spruce Biosciences, Inc. · NASDAQ:SPRB
Citadel Advisors LLC reported a 5.10% stake in Spruce Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Citadel Advisors LLC reported a 5.10% stake in Spruce Biosciences, Inc., 69,999 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 69,999
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 5.10% | 69,999 |
| Citadel Advisors Holdings LP | 5.10% | 69,999 |
| Citadel GP LLC | 5.10% | 69,999 |
| Citadel Securities LLC | 0% | 66 |
| Citadel Securities Group LP | 0% | 66 |
| Citadel Securities GP LLC | 0% | 66 |
| Kenneth Griffin | 5.10% | 70,065 |
Source
Related
- Spruce Biosciences, Inc.
- Citadel Advisors LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Oct 16, 2025
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026